Cargando…

Lenalidomide Desensitization in Systemic Light-Chain Amyloidosis With Multi-Organ Involvement

Limited therapeutic options are available to amyloid patients treated with many lines of therapy. Although combination therapy using lenalidomide and dexamethasone is an effective sequential regimen for systemic amyloidosis (AL), dexamethasone is often poorly tolerated in patients with cardiac invol...

Descripción completa

Detalles Bibliográficos
Autores principales:	Seki, Jack T., Sakurai, Naoko, Kukreti, Vishal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elmer Press 2015
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4554222/ https://www.ncbi.nlm.nih.gov/pubmed/26346623 http://dx.doi.org/10.14740/jocmr2303e

Ejemplares similares

Systemic Immunoglobulin Light Chain Amyloidosis Involving the Large Intestine
por: Swaminathan, Renugadevi, et al.
Publicado: (2021)

Multiorgan involvement by amyloid light chain amyloidosis
por: Li, Guoliang, et al.
Publicado: (2019)

Case for diagnosis. Systemic light chain amyloidosis with cutaneous involvement
por: Gontijo, João Renato Vianna, et al.
Publicado: (2017)

Systemic Light Chain Amyloidosis Mimicking Rheumatic Disorders
por: Rao, Rohit R., et al.
Publicado: (2016)

Muscle involvement with pseudohypertrophy in systemic light chain amyloidosis: Case report
por: Draghici, Mirela, et al.
Publicado: (2021)

The clinical features and outcomes of systemic light chain amyloidosis with hepatic involvement
por: Zhao, Liang, et al.
Publicado: (2022)

Light Chain Amyloidosis
por: Milani, Paolo, et al.
Publicado: (2018)

Localized Lymph Node Light Chain Amyloidosis
por: Dhakal, Binod, et al.
Publicado: (2015)

Localized Lymph Node Light Chain Amyloidosis
por: Yamamoto, Akira, et al.
Publicado: (2020)

Light chain amyloidosis presenting as retiform purpura
por: Soliman, Yssra S., et al.
Publicado: (2021)

A rare cause of colonic pseudo-obstruction due to light chain amyloidosis
por: Deng, Yunpeng (Jack), et al.
Publicado: (2023)

Direct Factor X sequestration by systemic amyloid light‐chain amyloidosis
por: Tashiro, Haruko, et al.
Publicado: (2018)

Cardiac involvement in light chain amyloidosis: a case report
por: Li, Jing, et al.
Publicado: (2020)

Progressive chorioretinal involvement in a patient with light-chain (AL) amyloidosis: a case report
por: Augstburger, Edouard, et al.
Publicado: (2020)

Apolipoprotein C-II Deposition Amyloidosis: A Potential Misdiagnosis as Light Chain Amyloidosis
por: Lohani, Sadichhya, et al.
Publicado: (2016)

Cardiac biomarkers are prognostic in systemic light chain amyloidosis with no cardiac involvement by standard criteria
por: Sharpley, Faye A., et al.
Publicado: (2020)

Gastrointestinal Polyps and Hemorrhage as a Presentation of Primary Systemic Light Chain Amyloidosis
por: Suchartlikitwong, Sakolwan, et al.
Publicado: (2018)

Nasopharyngeal amyloidoma with osteolytic lesions leading to diagnosis of systemic light‐chain amyloidosis
por: Susanibar‐Adaniya, Sandra, et al.
Publicado: (2017)

T1 mapping and survival in systemic light-chain amyloidosis
por: Banypersad, Sanjay M., et al.
Publicado: (2015)

Multidisciplinary supportive care in systemic light chain amyloidosis
por: Maroun, Bou Zerdan, et al.
Publicado: (2022)

Light-chain cardiac amyloidosis with neuropathy: a case report
por: Xu, Zhan-Wen, et al.
Publicado: (2015)

A Rare Case of Light Chain Amyloidosis of the Gastrointestinal Tract
por: Dvir, Kathrin, et al.
Publicado: (2020)

Localized Immunoglobulin Light-Chain Amyloidosis of the Ulnar Nerve
por: Morisaki, Shinsuke, et al.
Publicado: (2021)

Undiagnosed light chain systemic amyloidosis: does it matter to anesthesiologists? -a case report-
por: Kim, Gwan Ho, et al.
Publicado: (2013)

Novel Therapies in Light Chain Amyloidosis
por: Milani, Paolo, et al.
Publicado: (2017)

DUAL expectations in light chain amyloidosis
por: Schönland, Stefan, et al.
Publicado: (2020)

Lenalidomide as a Beneficial Treatment Option for Renal Impairment Caused by Light Chain Deposition Disease
por: Kimura, Satoshi, et al.
Publicado: (2018)

Significant role of magnetic resonance imaging for the diagnosis and evaluation of cardiac amyloidosis in primary light chain amyloidosis
por: Sekiguchi, Yasunobu, et al.
Publicado: (2020)

Hybrids of Physarum myosin light chains and desensitized scallop myofibrils
Publicado: (1981)

Systemic light chain amyloidosis myopathy responsive to daratumumab monotherapy
por: Chitimus, Diana Maria, et al.
Publicado: (2022)

Safety and efficacy of teclistamab in systemic immunoglobulin light chain amyloidosis
por: Chakraborty, Rajshekhar, et al.
Publicado: (2023)

Sars-Cov-2 Infection and Systemic Light Chain Amyloidosis: The International Society of Amyloidosis' Survey
por: Milani, Paolo, et al.
Publicado: (2020)

Hepatic Involvement as the Sole Presentation of Systemic Amyloid Light Chain (AL) Amyloidosis: A Diagnostic Challenge
por: Kottavadakkeel, Nadeer, et al.
Publicado: (2023)

A Case of Localized Amyloid Light-Chain Amyloidosis in the Small Intestine
por: Choi, Jong Hyo, et al.
Publicado: (2014)

Localized Gastric Amyloidosis with Kappa and Lambda Light Chain Co-Expression
por: Ahn, Yong Hwan, et al.
Publicado: (2018)

Acquired Factor X Deficiency in Patients With Primary Light Chain Amyloidosis
por: Dejhansathit, Siroj, et al.
Publicado: (2019)

Recurrent Syncope and Cardiac Arrest in a Patient with Systemic Light Chain Amyloidosis Treated with Bortezomib
por: Jaipaul, Navin, et al.
Publicado: (2016)

Autopsy findings in a patient with primary systemic AL (kappa light chain) amyloidosis
por: Ledesma, Felipe Lourenço, et al.
Publicado: (2021)

RUNX proteins desensitize multiple myeloma to lenalidomide via protecting IKZFs from degradation
por: Zhou, Nan, et al.
Publicado: (2019)

Importance of FISH genetics in light chain amyloidosis
por: Gertz, Morie A., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_fndpf8tp0ir688t2f5gnufdtnm